SCHEMBL38157

SCHEMBL38157

O=C(O)CCC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27890788 1.00 LMNA (0.47)
Hydrochloric Acid SCHEMBL6338625 0.97 LMNA (0.44)
Oxalic Acid SCHEMBL28801176 0.94 LMNA (0.42)
Trifluoroacetic Acid SCHEMBL30548554 0.92 ALDH1A1 (0.41)
SCHEMBL15346753 0.84 ACE (0.48)
Oxalic Acid SCHEMBL2420699 0.83 EGLN1 (0.37)
SCHEMBL565341 0.82 LMNA (0.53)
SCHEMBL9437327 0.81 LMNA (0.47)
SCHEMBL12987414 0.81 LMNA (0.47)
SCHEMBL866445 0.80 LMNA (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1797 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3523280-B1 PROCESSES AND INTERMEDIATES FOR PREPARING A BTK INHIBITOR JANSSEN PHARMACEUTICA NV (BE) 2026-03-11 EP claimed
EP-4262788-B1 UREA OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME LLC (US) 2026-01-21 EP claimed
US-20250329799-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY Anthro Energy, Inc. (US) 2025-10-23 US claimed
WO-2025202864-A1 ENT1 INHIBITORS IN COMBINATION WITH ONCOLYTIC VIRUSES AND THEIR USE IN THE TREATMENT OF CANCER iTeos Belgium SA (BE) 2025-10-02 WO claimed
EP-4427281-B1 LITHIUM-ION ELECTROCHEMICAL ELEMENT ACCUMULATEURS FIXES (FR) 2025-09-10 EP claimed
EP-4599674-A1 USE OF SULFOXAMYL, PREPARATION METHOD THEREFOR, AND OXIDATION SYSTEM Ningxia Hugerise Chemical Co., Ltd. (CN) 2025-08-13 EP claimed
US-20250221413-A1 Use and Preparation Method of Sulfoxamyl, and Oxidation System NINGXIA HUGERISE CHEMICAL CO., LTD. (CN) 2025-07-10 US claimed
WO-2025126110-A1 ENT1 INHIBITORS IN COMBINATION WITH BISPECIFIC ANTIBODIES iTeos Belgium SA (BE) 2025-06-19 WO claimed
WO-2025104613-A1 ENT1 INHIBITORS IN COMBINATION WITH CHECKPOINT INHIBITORS iTeos Belgium SA (BE) 2025-05-22 WO claimed
CN-119907612-A Perovskite precursor solution, perovskite solar cell and preparation method of perovskite precursor solution 中国科学技术大学 2025-04-29 CN claimed
EP-0861072-A2 COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS TRUSTEES OF BOSTON UNIVERSITY (US) 1998-09-02 EP claimed
EP-0850221-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1998-07-01 EP claimed
WO-1998004290-A2 COMPOSITIONS COMPRISING AN INDUCING AGENT AND AN ANTI-VIRAL AGENT FOR THE TREATMENT OF BLOOD, VIRAL AND CELLULAR DISORDERS PERRINE SUSAN P (US) 1998-02-05 WO claimed
WO-1997008145-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-03-06 WO claimed
WO-1996027369-A9 COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS 1996-12-27 WO claimed
WO-1996027369-A2 COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS THE TRUSTEES OF BOSTON UNIVERSITY (US) 1996-09-12 WO claimed
EP-0332392-B1 Dioxane liquid crystal compounds SHOWA SHELL SEKIYU (JP) 1994-12-07 EP claimed
US-5144037-A Viricides G. D. SEARLE & CO. (US) 1992-09-01 US claimed
EP-0494850-A2 Novel antiviral compounds G.D. Searle &amp; Co. (US) 1992-07-15 EP claimed
US-4161611-A Process for the production of 2-methoxy-3,6-dichlorobenzoic acid Veesicol Chemical Corporation (US) 1979-07-17 US claimed